Filing Details
- Accession Number:
- 0001237899-13-000023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-03 16:09:17
- Reporting Period:
- 2013-05-01
- Filing Date:
- 2013-05-03
- Accepted Time:
- 2013-05-03 16:09:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1403178 | S Douglas Mccorkle | 777 Old Saw Mill River Road Tarrytown NY 10591 | Vp Controller & Asst Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-01 | 5,875 | $52.03 | 9,875 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-01 | 1,308 | $233.53 | 8,567 | No | 4 | F | Direct | |
Common Stock | Disposition | 2013-05-01 | 2,354 | $233.53 | 6,213 | No | 4 | F | Direct | |
Common Stock | Disposition | 2013-05-02 | 620 | $241.45 | 5,593 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-05-02 | 100 | $242.38 | 5,493 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-05-02 | 100 | $243.09 | 5,393 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-05-02 | 100 | $244.30 | 5,293 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-05-02 | 100 | $245.95 | 5,193 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-05-02 | 600 | $246.43 | 4,593 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-05-02 | 593 | $247.21 | 4,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-05-01 | 5,875 | $0.00 | 5,875 | $52.03 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
15,704 | 2021-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,066 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 620 shares of Company stock on May 2, 2013 at prices ranging from $241.03 to $241.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 2, 2013 at each separate price.
- Represents volume-weighted average price of sales of 600 shares of Company stock on May 2, 2013 at prices ranging from $246.17 to $246.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 2, 2013 at each separate price.
- Represents volume-weighted average price of sales of 593 shares of Company stock on May 2, 2013 at prices ranging from $247.03 to $247.42. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 2, 2013 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.